» Articles » PMID: 37374096

The Female Reproductive Tract Microbiota: Friends and Foe

Overview
Journal Life (Basel)
Specialty Biology
Date 2023 Jun 28
PMID 37374096
Authors
Affiliations
Soon will be listed here.
Abstract

We do not seem to be the only owner of our body; it houses a large population of microorganisms. Through countless years of coevolution, microbes and hosts have developed complex relationships. In the past few years, the impact of microbial communities on their host has received significant attention. Advanced molecular sequencing techniques have revealed a remarkable diversity of the organ-specific microbiota populations, including in the reproductive tract. Currently, the goal of researchers has shifted to generate and perceive the molecular data of those hidden travelers of our body and harness them for the betterment of human health. Recently, microbial communities of the lower and upper reproductive tract and their correlation with the implication in reproductive health and disease have been extensively studied. Many intrinsic and extrinsic factors influences the female reproductive tract microbiota (FRTM) that directly affects the reproductive health. It is now believed that FRTM dominated by may play an essential role in obstetric health beyond the woman's intimate comfort and well-being. Women with altered microbiota may face numerous health-related issues. Altered microbiota can be manipulated and restored to their original shape to re-establish normal reproductive health. The aim of the present review is to summarize the FRTM functional aspects that influence reproductive health.

Citing Articles

Vulvar Lichen Sclerosus: A Literature Review with Consideration of Integrative Therapies.

Jade K Integr Med (Encinitas). 2025; 24(1):16-25.

PMID: 39896832 PMC: 11778321.


Protective Mechanisms of Vaginal Lactobacilli against Sexually Transmitted Viral Infections.

Avitabile E, Menotti L, Croatti V, Giordani B, Parolin C, Vitali B Int J Mol Sci. 2024; 25(17).

PMID: 39273118 PMC: 11395631. DOI: 10.3390/ijms25179168.


Understanding the Role of Female Genital Tract Microbiome in Recurrent Implantation Failure.

Lafioniatis A, Samara A, Makaritsis P, Dafopoulos S, Sotiriou S, Dafopoulos K J Clin Med. 2024; 13(11).

PMID: 38892884 PMC: 11172434. DOI: 10.3390/jcm13113173.


Cervical microbiota dysbiosis associated with high-risk Human Papillomavirus infection.

Zeber-Lubecka N, Kulecka M, Dabrowska M, Baginska-Drabiuk K, Glowienka-Stodolak M, Nowakowski A PLoS One. 2024; 19(4):e0302270.

PMID: 38669258 PMC: 11051640. DOI: 10.1371/journal.pone.0302270.


Cervicovaginal microbiota: a promising direction for prevention and treatment in cervical cancer.

Shen J, Sun H, Chu J, Gong X, Liu X Infect Agent Cancer. 2024; 19(1):13.

PMID: 38641803 PMC: 11027553. DOI: 10.1186/s13027-024-00573-8.


References
1.
Tomaiuolo R, Veneruso I, Cariati F, DArgenio V . Microbiota and Human Reproduction: The Case of Female Infertility. High Throughput. 2020; 9(2). PMC: 7349014. DOI: 10.3390/ht9020012. View

2.
Peterson J, Garges S, Giovanni M, McInnes P, Wang L, Schloss J . The NIH Human Microbiome Project. Genome Res. 2009; 19(12):2317-23. PMC: 2792171. DOI: 10.1101/gr.096651.109. View

3.
Makarova K, Slesarev A, Wolf Y, Sorokin A, Mirkin B, Koonin E . Comparative genomics of the lactic acid bacteria. Proc Natl Acad Sci U S A. 2006; 103(42):15611-6. PMC: 1622870. DOI: 10.1073/pnas.0607117103. View

4.
Kacerovsky M, Vrbacky F, Kutova R, Pliskova L, Andrys C, Musilova I . Cervical microbiota in women with preterm prelabor rupture of membranes. PLoS One. 2015; 10(5):e0126884. PMC: 4439143. DOI: 10.1371/journal.pone.0126884. View

5.
Petricevic L, Rosicky I, Kiss H, Janjic N, Kaufmann U, Holzer I . Effect of vaginal probiotics containing Lactobacillus casei rhamnosus (Lcr regenerans) on vaginal dysbiotic microbiota and pregnancy outcome, prospective, randomized study. Sci Rep. 2023; 13(1):7129. PMC: 10154324. DOI: 10.1038/s41598-023-34275-9. View